BioVendor MDx:
Experts in Molecular Diagnostics
We search for ways to accelerate the introduction of reliable, affordable and personalised diagnostics into laboratory practice.
Our mission is to develop new solutions for molecular laboratories, especially diagnostic tools for innovative methods of molecular diagnostics – NGS, LAMP and miRNA from BioVendor Group laboratories.
Behind innovation lies partnership:
GENOVESA by Bioxsys and BioVendor Group
Bioxsys s.r.o.
Bioxsys is a Czech company specializing in the development of software solutions for bioinformatics and genetic data analysis. Their products are designed to facilitate the interpretation of complex genetic information and support precision medicine. The company emphasizes innovation and collaborates with leading scientific institutions and healthcare organizations. With expertise in bioinformatics and genetics, Bioxsys contributes to advancements in the diagnosis and treatment of genetic disorders.
BioVendor MDx is a proud member
of the BioVendor Group
We are exploring better ways to diagnose.
We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.
Our strategy is anchored by three key projects – CLIA, MBA, and NGS – focusing our innovation and delivery across next-generation sequencing, chemiluminescent immunoassays, and Microblot-Array. By combining scientific excellence, strong innovation capacity, and a presence in more than 100 markets worldwide, we deliver solutions that advance laboratory practice and patient care, making us one of the key players in clinical diagnostics.
